Reply by Authors.

Abstract

No AccessJournal of UrologyAdult Urology1 Jun 2021Reply by Authorsis a reply to letterEditorial CommentEditorial Comment Justin T. Matulay, Roger Li, Patrick J. Hensley, Nathan A. Brooks, Vikram M. Narayan, H. Barton Grossman, Neema Navai, Colin P. N. Dinney, and Ashish M. Kamat Justin T. MatulayJustin T. Matulay http://orcid.org/0000-0002-2467-5710 Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, North Carolina More articles by this author , Roger LiRoger Li Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida More articles by this author , Patrick J. HensleyPatrick J. Hensley http://orcid.org/0000-0002-8098-901X Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas Financial interest and/or other relationship with AUA Urology Care Foundation. More articles by this author , Nathan A. BrooksNathan A. Brooks Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Vikram M. NarayanVikram M. Narayan http://orcid.org/0000-0003-3731-4209 Department of Urology, Emory University School of Medicine, Atlanta, Georgia More articles by this author , H. Barton GrossmanH. Barton Grossman Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Neema NavaiNeema Navai http://orcid.org/0000-0001-8457-3786 Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Colin P. N. DinneyColin P. N. Dinney http://orcid.org/0000-0002-8969-711X Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas Financial interest and/or other relationship with NIH and FKD. More articles by this author , and Ashish M. KamatAshish M. Kamat §Correspondence: University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1373, Houston, Texas 77030 E-mail Address: [email protected] http://orcid.org/0000-0003-3546-9928 Urologic Oncology (Surgery), Wayne B. Duddlesten Professor of Cancer Research, University of Texas MD Anderson Cancer Center, Houston, Texas Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas Financial interest and/or other relationship with FKD, Merck, BMS, Photocure, NIH, AIBCCR, Arquer, Theralase, Medac, Pfizer, Astra Zeneca, Imagin, Eisai/H3 Biomedicine, Cold Genesys, Sessen Bio, enGene, Janssen, ArTara, Seattle Genetics, FerGene More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001633.03AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Reply by Authors." The Journal of Urology, 205(6), pp. 1620–1621 © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyMar 18, 2021, 12:00:00 AMEditorial CommentJournal of UrologyMar 18, 2021, 12:00:00 AMEditorial Comment Volume 205Issue 6June 2021Page: 1620-1621 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Justin T. Matulay Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, North Carolina More articles by this author Roger Li Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida More articles by this author Patrick J. Hensley Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas Financial interest and/or other relationship with AUA Urology Care Foundation. More articles by this author Nathan A. Brooks Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Vikram M. Narayan Department of Urology, Emory University School of Medicine, Atlanta, Georgia More articles by this author H. Barton Grossman Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Neema Navai Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Colin P. N. Dinney Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas Financial interest and/or other relationship with NIH and FKD. More articles by this author Ashish M. Kamat Urologic Oncology (Surgery), Wayne B. Duddlesten Professor of Cancer Research, University of Texas MD Anderson Cancer Center, Houston, Texas Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas §Correspondence: University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1373, Houston, Texas 77030 E-mail Address: [email protected] Financial interest and/or other relationship with FKD, Merck, BMS, Photocure, NIH, AIBCCR, Arquer, Theralase, Medac, Pfizer, Astra Zeneca, Imagin, Eisai/H3 Biomedicine, Cold Genesys, Sessen Bio, enGene, Janssen, ArTara, Seattle Genetics, FerGene More articles by this author Expand All Advertisement Loading ...